Rep. Richard W. Allen discloses trade(s) in ABT, AMD, AVGO
Richard W. Allen (GA12) disclosed 3 transactions, traded Jul 14: 2 purchases and 1 sale.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jul 14 | ABT | Abbott Laboratories | Sell | $15,001 - $50,000 | Spouse |
| Jul 14 | AMD | Advanced Micro Devices, Inc. | Buy | $1,001 - $15,000 | Spouse |
| Jul 14 | AVGO | Broadcom Inc. | Buy | $1,001 - $15,000 | Spouse |
ORIGINAL FILING ↗ALL FILINGS BY RICHARD W. ALLEN →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. representative has filed a financial disclosure covering stock transactions in Abbott Laboratories, Advanced Micro Devices, and Broadcom. Congressional stock trading disclosures are tracked as part of transparency requirements and governance oversight. Such filings can signal insider positioning or be monitored for potential conflicts of interest, though individual trades require context on timing and size to assess market relevance.
Sources (1)
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Richard W. AllenSep 26, 2026View the original filing at the House Clerk ↗
How This Could Play Out
First assessed Sep 26
Resolved
UNLIKELYA congressional disclosure filing itself has no resolution mechanism—it is a completed administrative act. The trades occurred in July; the filing in August is the end state, not a beginning.
Status quo
LIKELYRoutine STOCK Act filings by individual members typically attract minimal market attention unless part of a broader pattern of coordinated trading or advance knowledge of material events; isolated disclosures of this kind have historically been absorbed without measurable price impact on the underlying securities.
Worsens
POSSIBLEIf subsequent reporting or investigation were to reveal these trades occurred on the basis of material nonpublic information obtained through committee work or advance knowledge of regulatory action affecting semiconductors or healthcare, scrutiny of the member's trading practices could intensify, though direct market impact would depend on the scope and nature of any alleged violation.
SPONSORED
More on Congressional Stock Trading
- Rep. James A. Himes files a Periodic Transaction ReportOct 20
- Rep. Jonathan Jackson discloses trade(s) in DDOG, EL, GH, TYG, VSATOct 19
- Rep. Michael Rulli discloses trade(s) in GOOG, WSBCOct 19
- Attorneys for Ilhan Omar seek return of items taken during home searchOct 17
- Rep. Laurel Lee discloses trade(s) in BAC, NOKBFOct 16
- Rep. Scott H. Peters files a Periodic Transaction ReportOct 15
Get the market digest by email
One email each morning: yesterday's key story and what it means for markets. Free.